Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

This study is currently recruiting participants.

Study NCT00627354 Information provided by National Cancer Institute (NCI)

First Received: February 29, 2008 Last Updated: July 7, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	September 2008 (Final data collection date for primary outcome measure)